Guiding Good Choices for Health
GGC4H
A Pragmatic Trial of Parent-focused Prevention in Pediatric Primary Care
2 other identifiers
interventional
3,636
1 country
3
Brief Summary
This study evaluates the feasibility and effectiveness of implementing Guiding Good Choices (GGC), an anticipatory guidance curriculum for parents of early adolescents, in three large, integrated healthcare systems. By "parents," the study team is referring here and throughout this protocol to those adults who are the primary caregivers of children, irrespective of their biological relationship to the child. In prior community trials, GGC has been shown to prevent adolescent substance use (alcohol, tobacco, and marijuana), depressive symptoms, and delinquent behavior. This study offers an opportunity to test GGC effectiveness with respect to improving adolescent behavioral health outcomes when implemented at scale in pediatric primary care within a pragmatic trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2019
CompletedFirst Posted
Study publicly available on registry
July 31, 2019
CompletedStudy Start
First participant enrolled
September 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedJune 3, 2024
May 1, 2024
5.7 years
July 27, 2019
May 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of adolescent substance use initiation (alcohol, cigarettes, e-cigarettes, and/or marijuana) through last follow-up
Substance use initiation by the study's endpoint will be operationalized by a dichotomous indicator of ever use (yes/no) of alcohol, cigarettes, e-cigarettes, or marijuana formed from adolescent prospective self-reports about their lifetime use of these substances in each data collection wave. Substances will be assessed by separate items, e.g., "Have you ever used marijuana (by used we mean smoked, vaped, eaten, etc.)," "Have you ever used an e-cigarette or vaped ("Juul," "e-hookah," etc.)?" Lifetime use by last follow-up will be indicated by reported use of any of the substances in any wave. Lack of use will be indicated by no reported use of any of the substances in all waves.
Final follow-up in year 5 of study
Secondary Outcomes (6)
Prevalence of any past-year substance use (alcohol, cigarettes, e-cigarettes, marijuana) by adolescents at final follow-up
3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
Prevalence of any past-30-day substance use (alcohol, cigarettes, e-cigarettes, marijuana) by adolescents at final follow-up
3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
Incidence of antisocial behavior among adolescents through final follow-up
3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
Mean adolescent depression symptom score at final follow-up
3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
Mean adolescent anxiety symptom score at final follow-up
3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
- +1 more secondary outcomes
Other Outcomes (6)
Prevalence of substance use disorders among adolescents through final extraction
3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
Prevalence of any psychiatric disorder (depression, anxiety, or conduct disorder) among adolescents through final extraction
3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
Prevalence of specialty substance use treatment services utilization by adolescents through final extraction
3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
- +3 more other outcomes
Study Arms (2)
Guiding Good Choices
EXPERIMENTALEnrollment in the intervention, Guiding Good Choices, a substance use initiation prevention program, will be recommended by the pediatrician to parents of those adolescents empaneled with an intervention arm pediatrician
Control
NO INTERVENTIONParents of adolescents empaneled with a control arm pediatrician will not be offered Guiding Good Choices
Interventions
Guiding Good Choices is a 5-session group-based prevention program for parents of early adolescents. Weekly 2.5 hour sessions will be held at participants' primary care clinics and led by two trained interventionists. Through didactic material, video segments, interactive activities, and home practice, the curriculum teaches parents to understand the progression from individual and environmental risk and protective factors to substance use and problem behavior, enhances parenting behaviors and skills, teaches effective family management skills, strengthens parent-adolescent interactions and bonding, broadens opportunities for family involvement, teaches conflict reduction and anger management skills, and teaches adolescents skills to resist peer influences to engage in risky behavior. Parents who opt not to attend groups will be offered a self-guided intervention manual containing the same core content and video access, plus supportive coaching to motivate use and address questions.
Eligibility Criteria
You may qualify if:
- Adolescent is empaneled with an intervention or control arm pediatrician in a participating clinic in one of the three healthcare systems (Kaiser Permanente Northern California, Kaiser Permanente Colorado, Henry Ford Health System)
- Adolescent is 12.00 - 12.99 years during intervention period (born between 6.1.2007 and 5.31.2009), which means that some adolescents may be 11 at baseline assessment
You may not qualify if:
- Parent's primary language is not English, as documented in the EHR or identified at study recruitment call
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- Kaiser Permanentecollaborator
- Henry Ford Health Systemcollaborator
- National Center for Complementary and Integrative Health (NCCIH)collaborator
Study Sites (3)
Kaiser Permanente Northern California
Oakland, California, 94612, United States
Kaiser Permanente Colorado
Aurora, Colorado, 80014, United States
Henry Ford Health System
Detroit, Michigan, 48202, United States
Related Publications (1)
Scheuer H, Kuklinski MR, Sterling SA, Catalano RF, Beck A, Braciszewski J, Boggs J, Hawkins JD, Loree AM, Weisner C, Carey S, Elsiss F, Morse E, Negusse R, Jessen A, Kline-Simon A, Oesterle S, Quesenberry C, Sofrygin O, Yoon T. Parent-focused prevention of adolescent health risk behavior: Study protocol for a multisite cluster-randomized trial implemented in pediatric primary care. Contemp Clin Trials. 2022 Jan;112:106621. doi: 10.1016/j.cct.2021.106621. Epub 2021 Nov 14.
PMID: 34785305DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret R Kuklinski, PhD
University of Washington
- PRINCIPAL INVESTIGATOR
Richard F Catalano, PhD
University of Washington
- PRINCIPAL INVESTIGATOR
Stacy A Sterling, DrPH
Kaiser Permanente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
July 27, 2019
First Posted
July 31, 2019
Study Start
September 30, 2019
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
June 3, 2024
Record last verified: 2024-05